Skip to main navigation Skip to search Skip to main content

FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway

  • Mei Shi Yeo*
  • , Vinod Vijay Subhash
  • , Kazuto Suda
  • , Hayri Emrah Balcioglu
  • , Siqin Zhou
  • , Win Lwin Thuya
  • , Xin Yi Loh
  • , Sriganesh Jammula
  • , Praveen C. Peethala
  • , Shi Hui Tan
  • , Chen Xie
  • , Foong Ying Wong
  • , Benoit Ladoux
  • , Yoshiaki Ito
  • , Henry Yang
  • , Boon Cher Goh
  • , Lingzhi Wang*
  • , Wei Peng Yong*
  • *Corresponding author for this work
  • National University Hospital (Singapore)
  • The University of Sydney and the University of New South Wales, Bankstown-Lidcombe Hospital, Australia
  • Aichi Cancer Center Hospital and Research Institute
  • Centre National de la Recherche Scientifique (CNRS)
  • National University of Singapore

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Web of Science)
25 Downloads (Pure)

Abstract

F-box/WD repeat-containing protein 5 (FBXW5) is a member of the FBXW subclass of F-box proteins. Despite its known function as a component of the Skpl-Cullin-F-box (SCF) ubiquitin ligase complex, the role of FBXW5 in gastric cancer tumorigenesis and metastasis has not been investigated. The present study investigates the role of FBXW5 in tumorigenesis and metastasis, as well as the regulation of key signaling pathways in gastric cancer; using in-vitro FBXW5 knockdown/overexpression cell line and in-vivo models. In-vitro knockdown of FBXW5 results in a decrease in cell proliferation and cell cycle progression, with a concomitant increase in cell apoptosis and caspase-3 activity. Furthermore, knockdown of FBXW5 also leads to a down regulation in cell migration and adhesion, characterized by a reduction in actin polymerization, focal adhesion turnover and traction forces. This study also delineates the mechanistic role of FBXW5 in oncogenic signaling as its inhibition down regulates RhoA-ROCK 1 (Rho-associated protein kinase 1) and focal adhesion kinase (FAK) signaling cascades. Overexpression of FBXW5 promotes in-vivo tumor growth, whereas its inhibition down regulates in-vivo tumor metastasis. When considered together, our study identifies the novel oncogenic role of FBXW5 in gastric cancer and draws further interest regarding its clinical utility as a potential therapeutic target.
Original languageEnglish
Number of pages21
JournalCancers
Volume11
Issue number6
DOIs
Publication statusPublished - 17 Jun 2019
Externally publishedYes

Bibliographical note

Funding:
This study was funded by the translational research grant, (Grant number: NMRC/TCR/009-NUH/2013),
the National Medical Research Council (NMRC) TCR grant (Grant number: NR12NMR175) and the Centre grant
(Grant number: NR13NMR108).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway'. Together they form a unique fingerprint.

Cite this